At Olpha, we study and conduct various solid oral dosage form development (tablets, capsules, powder dosages). We develop the finished dosage forms at newly constructed and modern research laboratories with access to all state-of-the-art instruments and facilities for the development of finished dosage forms and analytical support. In the drug research and development process, we employ the modern design of experiments (DoE) approach.
The laboratory of finished dosage forms features also a pilot section, where we perform scaling works of the developed technologies and where we can manufacture small finished product series, including final packaging. We strictly observe all principles of Good Manufacturing Practice.
Formulation development and optimisation (for tablets, capsules, sachets)
Production of scalable series, i.e. from pilot series to validation series.
Execution of drug and excipient compatibility studies
Transfer of the developed technology to production